Trial Profile
A safety trial of bevacizumab to show that it can be infused safely over 10 minutes in patients with metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 12 Dec 2015 New trial record